Learn how AbbVie and Ironwood can help you save on LINZESS. Call 1-855-226-3937 or click to LEARN MORE ▸
It's a once-daily pill that helps you have more frequent and complete bowel movements and helps relieve belly pain and overall abdominal symptoms* (pain, discomfort, and bloating) associated with IBS-C.
*Abdominal symptoms were studied in combination, not individually.
How linzess can help
*Abdominal symptoms were studied in combination, not individually.
Take the 5-question Gut Check to learn more about IBS-C symptoms and how LINZESS may help.
Finding relief may seem like a lot of trial and error. If your symptoms keep coming back, take the next step and ask a doctor about treatment options.
*Maximum savings limit applies; patient out-of-pocket expense may vary. This offer is available to patients with commercial prescription insurance coverage for a valid prescription of LINZESS® (linaclotide) at the time the prescription is filled by the pharmacist and dispensed to the patient. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please see Program Terms, Conditions, Privacy Notice, and Eligibility Criteria.
LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.
IMPORTANT RISK INFORMATION
Before you take LINZESS, tell your doctor about your medical conditions, including if you are:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Side Effects
LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.
Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).
Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.
These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
US-LIN-230214
For adults with Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Idiopathic Constipation (CIC)
Answer a few quick questions about your symptoms.
Connect with a doctor online to find out if it could be IBS-C or CIC.
If approved, pick up your prescription from your local pharmacy.
*Third-party website; does not constitute an endorsement or recommendation by AbbVie. A fee will be charged by the telemedicine provider.
You are now leaving LINZESS.com
By clicking “Acknowledge and Continue” above, you acknowledge and agree that neither AbbVie nor Ironwood does, in any way, endorse or recommend UpScript, a telemedicine provider, the qualifications of any physician associated with UpScript, or the quality of medical care any of those physicians can provide. You also acknowledge and agree that neither AbbVie nor Ironwood makes any guarantees that using UpScript will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie and Ironwood recommend that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE, IRONWOOD, AND THEIR RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE. If you agree to the above, click “Acknowledge and Continue” to proceed to the UpScript website. If you do not agree to the above, click “Cancel” to remain on LINZESS.com.
LINZESS is approved for the treatment of
functional constipation (FC) in pediatric
patients 6 to 17 years of age.
Please see full Prescribing Information, including
BOXED WARNING and Medication Guide
US-LIN-230086
